BMS-919373

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBMS-919373
Drug Alias NameIkur inhibitor - Bristol-Myers SquibbBMS-919373
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.5 blockers
TargetsVoltage-gated potassium channel subunit Kv1.5
Therapy Area/IndicationsAcute Coronary SyndromeAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb Srlcompany
Active IndicationsN/A
Inactive IndicationsAcute Coronary SyndromeAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A